Lp-PLA2-IN-11 is a potent inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), which was previously known as platelet-activating factor acetylhydrolase (PAF-AH) and is involved in the hydrolysis of lipids or phospholipids in lipoproteins. It has potential for the investigation of diseases associated with Lp-PLA2 activity, such as atherosclerosis and Alzheimer's disease.